(Q38549616)

4 September 2017

1 reference

title

Endothelial progenitor cells accelerate the resolution of deep vein thrombosis (English)

1 reference

4 September 2017

0 references

1 reference

Wen-Dong Li

1

1 reference

4 September 2017

Xiao-Qiang Li

series ordinal

2

1 reference

4 September 2017

publication date

14 July 2015

1 reference

4 September 2017

published in

Vascular Pharmacology

1 reference

4 September 2017

volume

83

1 reference

4 September 2017

page(s)

10-16

1 reference

Deletion of cysteine-cysteine receptor 7 promotes fibrotic injury in experimental post-thrombotic vein wall remodeling

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Relationship between deep venous thrombosis and the postthrombotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

The vascularisation of deep-vein thrombi and their fibrous residue: a post mortem angio-graphic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Isolation of putative progenitor endothelial cells for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cells bind and inhibit platelet function and thrombus formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Concise review: Circulating endothelial progenitor cells for vascular medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Role of blood mononuclear cells in recanalization and vascularization of thrombi: past, present, and future.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cells are recruited into resolving venous thrombi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

The role of neovascularisation in the resolution of venous thrombus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cells: characterization and role in vascular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Upregulation of MicroRNA-126 Contributes to Endothelial Progenitor Cell Function in Deep Vein Thrombosis via Its Target PIK3R2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

MiR-150 enhances the motility of EPCs in vitro and promotes EPCs homing and thrombus resolving in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cells--an evolving story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

The therapeutic role of endothelial progenitor cells in Type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Evaluation of circulating endothelial progenitor cells in cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cells: new hope for a broken heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Circulating endothelial progenitor cells predict coronary artery disease severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cells as therapeutic agents in the microcirculation: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Contribution of endothelial progenitor cells to neovascularization (Review).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Human endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Circulating endothelial progenitor cells: Do they live up to their name?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cell-based neovascularization: implications for therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Exposure to platelets promotes functional properties of endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Adherent Platelets Recruit and Induce Differentiation of Murine Embryonic Endothelial Progenitor Cells to Mature Endothelial Cells In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Platelet-Derived Growth Factor CC — A Clinically Useful Angiogenic Factor at Last?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Proteases and receptors in the recruitment of endothelial progenitor cells in neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Tissue plasminogen activator enhances mobilization of endothelial progenitor cells and angiogenesis in murine limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Retention of endothelial progenitor cells in bone marrow in a murine model of endogenous tissue plasminogen activator (tPA) deficiency in response to critical limb ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial precursors in vascular repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

SDF-1alpha-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

The role of FGF and VEGF in angioblast induction and migration during vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Mobilized Endothelial Progenitor Cells by Granulocyte-Macrophage Colony-Stimulating Factor Accelerate Reendothelialization and Reduce Vascular Inflammation After Intravascular Radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Vascular repair by endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cells: sowing the seeds for vascular repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Circulating progenitor and mature endothelial cells in deep vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cells in vascular repair and remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Nitric oxide, a protective molecule in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Nitric oxide synthases: regulation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Nitric oxide and cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Cell-based therapy facilitates venous thrombus resolution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Transplantation of ex vivo expanded bone marrow-derived endothelial progenitor cells enhances chronic venous thrombus resolution and recanalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Inhibition of angiogenesis, fibrosis and thrombosis by tetramethylpyrazine: mechanisms contributing to the SDF-1/CXCR4 axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Interleukin-8 administration enhances venous thrombosis resolution in a rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Nitric oxide insufficiency, platelet activation, and arterial thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Intravenous release of NO from lipidic microbubbles accelerates deep vein thrombosis resolution in a rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

The biology of VEGF and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

A role for VEGF as a negative regulator of pericyte function and vessel maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Deep vein thrombosis resolution is not accelerated with increased neovascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Overexpression of matrix metalloproteinase-9 promotes intravascular thrombus formation in porcine coronary arteries in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Regulation of matrix biology by matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Vascular COX-2 modulates blood pressure and thrombosis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony-forming cell numbers and function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Outgrowth endothelial cells isolated and expanded from human peripheral blood progenitor cells as a potential source of autologous cells for endothelialization of silk fibroin biomaterials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Blood outgrowth endothelial cells from cord blood and peripheral blood: angiogenesis-related characteristics in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Signaling and functions of angiopoietin-1 in vascular protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

The Role of Angiotensin Type 1 Receptor in Inflammation and Endothelial Dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Angiopoietin-1 promotes endothelial differentiation from embryonic stem cells and induced pluripotent stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Angiotensin II-inducible smooth muscle cell apoptosis involves the angiotensin II type 2 receptor, GATA-6 activation, and FasL-Fas engagement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

TGFBIp regulates differentiation of EPC (CD133(+) C-kit(+) Lin(-) cells) to EC through activation of the Notch signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Platelet-derived growth factor-BB (PDGF-BB) induces differentiation of bone marrow endothelial progenitor cell-derived cell line TR-BME2 into mural cells, and changes the phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Role and mechanism of tissue plasminogen activator in venous wall fibrosis remodeling after deep venous thrombosis via the glycogen synthase kinase-3 beta signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Angiogenic Role of MMP-2/9 Expressed on the Cell Surface of Early Endothelial Progenitor Cells/Myeloid Angiogenic Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

Cerebral ischaemia and matrix metalloproteinase-9 modulate the angiogenic function of early and late outgrowth endothelial progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.07.007

10.1016/J.VPH.2015.07.007

7 January 2021

Identifiers

DOI

1 reference

4 September 2017

1 reference